Diabetic retinopathy, superoxide damage and antioxidants. - Wikidata - awgldk - TriplyDB

Diabetic retinopathy, superoxide damage and antioxidants.

Diabetic retinopathy, superoxide damage and antioxidants.

http://www.wikidata.org/entity/Q35545811

about

Epigenetic modifications and diabetic retinopathy Mitochondria in the pathogenesis of diabetes: a proteomic view NRF2 plays a protective role in diabetic retinopathy in mice Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon.Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.Arginase in retinopathy.Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.Mitochondrial biogenesis and the development of diabetic retinopathy High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes Damaged mitochondrial DNA replication system and the development of diabetic retinopathy.The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells.Prospectives for gene therapy of retinal degenerations Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.8-iso-prostaglandin-F2α: a possible trigger or accelerator of diabetic retinopathy.Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuropathy.Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.Targeting mitochondrial function to protect against vision loss.Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers.Deficits in Trabecular Bone Microarchitecture in Young Women With Type 1 Diabetes Mellitus.Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress.

P2860

Q21284810-54C365F6-CC21-4E0A-A5BD-67B4310361FB Q28394886-68D43574-BD97-4AD3-85A6-3FC35DC5C0A5 Q30579323-79826BA1-5B29-43CF-808E-C44BB0CB06DD Q33676124-B0C0D92D-2914-4128-93EC-EC6DEB90DCA5 Q33791268-D310DC45-6482-4378-96B2-3870B4A80AED Q34800913-2B66F712-E7CF-45C5-AF71-8AF32D958883 Q35073329-DE25251B-C62B-41D6-8818-16D483FB57B1 Q35457777-D2201476-BBE7-443A-A68B-F66AA2276211 Q35591494-F32AB318-F1AE-457C-92B5-3D0A513A8B39 Q35717950-F17F8F62-912A-4311-835D-A8F9D4C9C81F Q35912202-ABEEA18B-B0F1-4F39-A7E8-463254F1F0C6 Q36001839-559E2547-5EC1-44B9-9DE8-625ABD93E49B Q36041756-36306A8F-55ED-4103-9B59-A10791DB98D4 Q36108106-0FC045F6-752F-4EF1-B0BE-F013DA996454 Q36205231-B6F259AF-9818-443F-873C-3C8F4E158A17 Q36622437-72B6F2AC-10A8-44FE-BD7E-4BA27C3115B2 Q37242419-FEFB9B5E-AC1D-449A-B017-5006051DD2F8 Q37379837-AE827230-83C5-490F-B773-97A038B85012 Q37396370-123D2ED0-6ACA-45E0-BE4F-0581AFE6B433 Q38694794-0AB18A3C-2E93-4463-B95A-33E700DBC5A2 Q40134757-0F54A741-EB6F-49A3-A391-D6B20F5EBD97 Q46719927-76991F4A-0DCA-4798-B05D-9B277BD71338 Q50604480-C542DA2A-A42C-4127-9113-6DB17DF6D894 Q53520277-7DB0313D-9210-44E0-8685-8FCBB99B5FD5

P2860

Diabetic retinopathy, superoxide damage and antioxidants.

http://www.wikidata.org/entity/Q35545811

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Diabetic retinopathy, superoxide damage and antioxidants.

@ast

Diabetic retinopathy, superoxide damage and antioxidants.

@en

type

label

Diabetic retinopathy, superoxide damage and antioxidants.

@ast

Diabetic retinopathy, superoxide damage and antioxidants.

@en

prefLabel

Diabetic retinopathy, superoxide damage and antioxidants.

@ast

Diabetic retinopathy, superoxide damage and antioxidants.

@en

P1433

Q35545811-90919EAF-A191-4F3E-ADAA-7ECD2AE2873D

P1476

Q35545811-E276A860-1BF1-4940-8444-9526E5FF1C29

P2093

Q35545811-0D2B0603-754C-4827-802E-CE549681E914

Q35545811-789A16B8-4CBC-43EE-B78E-C9C57A61C363

P2860

Q35545811-0212CA4B-01F1-468A-9A7B-248D2C50EFFA

Q35545811-023E37DC-57B2-4027-B395-C2C72830D47F

Q35545811-041EE642-DEB8-4987-9F7F-21E89947FA02

Q35545811-04C6E124-00F9-4F2C-BD90-360E863D812C

Q35545811-086516D0-E52B-4D14-AEF6-64B7152C48D3

Q35545811-0914C281-100D-4FA4-B79E-947D2557210F

Q35545811-0DDA2FA6-BCA8-48E6-B3CC-D6654C1D5668

Q35545811-0F76E1E5-C5D6-4E29-BA63-DA126724BA0E

Q35545811-11858CA3-C797-4337-A5A7-49F308EADAFA

Q35545811-11D39343-988A-461A-B3B7-F2D19A234A46

P304

Q35545811-6F9D0F55-647C-4900-B807-314A390F883C

P31

Q35545811-0C52DDB7-A339-4D49-8F81-C64AB5A8AB59

P356

Q35545811-2D41E676-1FA7-4DDF-AD3E-2AFA906799ED

P433

Q35545811-4CD6EFC9-65A5-41C0-802F-4DCFB500A785

P478

Q35545811-0CB1BD21-1E22-493E-A01F-EBF8B39477A6

P50

Q35545811-CC41B4B0-B26F-4835-8609-3393149BF784

Q35545811-E32F9CBA-545B-405B-A504-1708DDEE5E5C

P577

Q35545811-7ADA5B44-5A5E-42EB-BE1B-6C7DAED06287

P5875

Q35545811-F4424F38-872C-4EFF-B21D-F5DA02DE5987

P698

Q35545811-53049B34-0613-4FDE-8328-F3E1E9A5814E

P932

Q35545811-E79275BC-D202-43F9-A0A4-9EFFB57B4A9D

P356

138920111794480507

P1433

Current Pharmaceutical Biotechnology

P1476

Diabetic retinopathy, superoxide damage and antioxidants

@en

P2093

Qing Zhong

http://www.w3.org/2001/XMLSchema#string

Renu A Kowluru

http://www.w3.org/2001/XMLSchema#string

P2860

Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2

Nitric oxide and peroxynitrite in health and disease

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Hyperglycemia increases mitochondrial superoxide in retina and retinal cells

Reactive oxygen species, cellular redox systems, and apoptosis

The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c

Complex III releases superoxide to both sides of the inner mitochondrial membrane

Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

P304

352-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/138920111794480507

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Ghulam Mohammad

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47403159

http://www.w3.org/2001/XMLSchema#string

P698

20939803

http://www.w3.org/2001/XMLSchema#string

P932

3214730

http://www.w3.org/2001/XMLSchema#string